A meta-analysis (87) that included 19 trials found that PD-1 blockade treatment was associated with a statistically significantly higher incidence of CIP than PD-L1 blockade (3.6% vs 1.3%, P=0.001). This evidence concerns the gene PDCD1 and hereditary sensory and autonomic neuropathy.